447 related articles for article (PubMed ID: 1954453)
1. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial.
Keays R; Harrison PM; Wendon JA; Forbes A; Gove C; Alexander GJ; Williams R
BMJ; 1991 Oct; 303(6809):1026-9. PubMed ID: 1954453
[TBL] [Abstract][Full Text] [Related]
2. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine.
Harrison PM; Keays R; Bray GP; Alexander GJ; Williams R
Lancet; 1990 Jun; 335(8705):1572-3. PubMed ID: 1972496
[TBL] [Abstract][Full Text] [Related]
3. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure.
Harrison PM; Wendon JA; Gimson AE; Alexander GJ; Williams R
N Engl J Med; 1991 Jun; 324(26):1852-7. PubMed ID: 1904133
[TBL] [Abstract][Full Text] [Related]
4. Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury.
Schmidt LE; Knudsen TT; Dalhoff K; Bendtsen F
Lancet; 2002 Oct; 360(9340):1151-2. PubMed ID: 12387966
[TBL] [Abstract][Full Text] [Related]
5. Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial.
; Dear J
Trials; 2019 Jan; 20(1):27. PubMed ID: 30621764
[TBL] [Abstract][Full Text] [Related]
6. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure.
Harrison PM; O'Grady JG; Keays RT; Alexander GJ; Williams R
BMJ; 1990 Oct; 301(6758):964-6. PubMed ID: 2249026
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction of hepatotoxicity in paracetamol poisoning.
Wong A; Graudins A
Clin Toxicol (Phila); 2017 Sep; 55(8):879-892. PubMed ID: 28447858
[TBL] [Abstract][Full Text] [Related]
8. A prospective observational study of a novel 2-phase infusion protocol for the administration of acetylcysteine in paracetamol poisoning.
Isbister GK; Downes MA; Mcnamara K; Berling I; Whyte IM; Page CB
Clin Toxicol (Phila); 2016; 54(2):120-6. PubMed ID: 26691690
[TBL] [Abstract][Full Text] [Related]
9. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2).
Chiew AL; Isbister GK; Kirby KA; Page CB; Chan BSH; Buckley NA
Clin Toxicol (Phila); 2017 Dec; 55(10):1055-1065. PubMed ID: 28644687
[TBL] [Abstract][Full Text] [Related]
10. Delays during the administration of acetylcysteine for the treatment of paracetamol overdose.
Bailey GP; Najafi J; Elamin ME; Waring WS; Thomas SH; Archer JR; Wood DM; Dargan PI
Br J Clin Pharmacol; 2016 Nov; 82(5):1358-1363. PubMed ID: 27412926
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation after paracetamol overdose.
O'Grady JG; Wendon J; Tan KC; Potter D; Cottam S; Cohen AT; Gimson AE; Williams R
BMJ; 1991 Jul; 303(6796):221-3. PubMed ID: 1884059
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in the management of paracetamol (acetaminophen) poisoning.
Janes J; Routledge PA
Drug Saf; 1992; 7(3):170-7. PubMed ID: 1503665
[TBL] [Abstract][Full Text] [Related]
13. Interventions for paracetamol (acetaminophen) overdose.
Brok J; Buckley N; Gluud C
Cochrane Database Syst Rev; 2006 Apr; (2):CD003328. PubMed ID: 16625578
[TBL] [Abstract][Full Text] [Related]
14. Fewer adverse effects associated with a modified two-bag intravenous acetylcysteine protocol compared to traditional three-bag regimen in paracetamol overdose.
Schmidt LE; Rasmussen DN; Petersen TS; Macias-Perez IM; Pavliv L; Kaelin B; Dart RC; Dalhoff K
Clin Toxicol (Phila); 2018 Nov; 56(11):1128-1134. PubMed ID: 29792347
[No Abstract] [Full Text] [Related]
15. Accuracy of the paracetamol-aminotransferase product to predict hepatotoxicity in paracetamol overdose treated with a 2-bag acetylcysteine regimen.
Wong A; Sivilotti MLA; Gunja N; McNulty R; Graudins A
Clin Toxicol (Phila); 2018 Mar; 56(3):182-188. PubMed ID: 28756679
[TBL] [Abstract][Full Text] [Related]
16. Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine.
Cairney DG; Beckwith HK; Al-Hourani K; Eddleston M; Bateman DN; Dear JW
Clin Toxicol (Phila); 2016 Jun; 54(5):405-10. PubMed ID: 27108714
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic modelling of modified acetylcysteine infusion regimens used in the treatment of paracetamol poisoning.
Wong A; Landersdorfer C; Graudins A
Eur J Clin Pharmacol; 2017 Sep; 73(9):1103-1110. PubMed ID: 28624886
[TBL] [Abstract][Full Text] [Related]
18. Safety of late acetylcysteine treatment in paracetamol poisoning.
Parker D; White JP; Paton D; Routledge PA
Hum Exp Toxicol; 1990 Jan; 9(1):25-7. PubMed ID: 2328143
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA from a 12-h versus 20-h acetylcysteine infusion for paracetamol overdose.
Wong A; Nejad C; Gantier M; Choy KW; Doery J; Graudins A
Hum Exp Toxicol; 2019 Jun; 38(6):646-654. PubMed ID: 30838890
[TBL] [Abstract][Full Text] [Related]
20. Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure.
Bray GP; Harrison PM; O'Grady JG; Tredger JM; Williams R
Hum Exp Toxicol; 1992 Jul; 11(4):265-70. PubMed ID: 1354974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
